Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ambrosi, Christina M ^a   Boyle, Patrick M ^b   Chen, Kay ^a   Trayanova, Natalia A ^b   Entcheva, Emilia ^a  

^a St Francis Hospital The Heart Center   (United States)

^b Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL THERAPY; EXCITATION; GENE THERAPY; GEOMETRY; HEART MUSCLE EXCITABILITY; HUMAN; ION CURRENT; OPTOGENETICS; QUANTITATIVE STUDY; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; ADENOVIRIDAE; ANIMAL; GENETIC TRANSDUCTION; GENETICS; HEART DISEASES; PATHOPHYSIOLOGY; PROCEDURES; RAT;

ADENOVIRIDAE; ANIMALS; GENETIC THERAPY; HEART DISEASES; OPTOGENETICS; RATS; TRANSDUCTION, GENETIC;

EID: 84949234875     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17350     Document Type: Article

References (50)

1. Tilemann, L., Ishikawa, K., Weber, T., Hajjar, R. J. Gene therapy for heart failure. Circ Res 110, 777-793 (2012).
2. Rosen, A. B. et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 25, 2128-2138 (2007).
3. Prasad, K. M., Smith, R. S., Xu, Y., French, B. A. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction. J Gene Med 13, 333-341 (2011).
4. Ambrosi, C. M. et al. Distribution of donor cells alters energy requirements for optogenetic control of the heart. Heart Rhythm 10, S96 (2013).
5. Prasad, K. M., Xu, Y., Yang, Z., Acton, S. T., French, B. A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 18, 43-52 (2011).
6. Vogt, C. C. et al. Systemic gene transfer enables optogenetic pacing of mouse hearts. Cardiovasc Res 106, 338-343 (2015).
7. Jessup, M. et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2 +ATPase in patients with advanced heart failure. Circulation 124, 304-313 (2011).
8. Hare, J. M. et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308, 2369-2379 (2012).
9. Malliaras, K. et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 63, 110-122 (2014).
10. Wu, J. C., Abraham, M. R., Kraitchman, D. L. Current perspectives on imaging cardiac stem cell therapy. J Nucl Med 51 Suppl 1, 128S-136S (2010).
11. Nagel, G. et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci USA 100, 13940-13945 (2003).
12. Arrenberg, A. B., Stainier, D. Y., Baier, H., Huisken, J. Optogenetic control of cardiac function. Science 330, 971-974 (2010).
13. Bruegmann, T. et al. Optogenetic control of heart muscle in vitro and in vivo. Nat Methods 7, 897-900 (2010).
14. Jia, Z. et al. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol 4, 753-760 (2011).
15. Abilez, O. J. et al. Multiscale computational models for optogenetic control of cardiac function. Biophys J 101, 1326-1334 (2011).
16. Williams, J. C. et al. Computational optogenetics: empirically-derived voltage-and light-sensitive channelrhodopsin-2 model. PLoS Comput Biol 9, e1003220 (2013).
17. Entcheva, E. Cardiac optogenetics. Am J Physiol Heart Circ Physiol 304, H1179-1191 (2013).
18. Ambrosi, C. M., Entcheva, E. Optogenetic Control of Cardiomyocytes via Viral Delivery. Methods Mol Biol 1181, 215-228 (2014).
19. Ambrosi, C. M., Klimas, A., Yu, J., Entcheva, E. Cardiac applications of optogenetics. Prog Biophys Mol Biol 115, 294-304 (2014).
20. Park, S. A., Lee, S. R., Tung, L., Yue, D. T. Optical mapping of optogenetically shaped cardiac action potentials. Sci Rep 4, 6125 (2014).
21. Karathanos, T. V., Boyle, P. M., Trayanova, N. A. Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. Europace 16 Suppl 4, iv69-iv76 (2014).
22. Boyle, P. M., Karathanos, T. V., Trayanova, N. A. "Beauty is a light in the heart": the transformative potential of optogenetics for clinical applications in cardiovascular medicine. Trends Cardiovasc Med 25, 73-81 (2015).
23. Boyle, P. M., Karathanos, T. V., Entcheva, E., Trayanova, N. A. Computational modeling of cardiac optogenetics: Methodology overview & review of findings from simulations. Comput Biol Med 65, 200-208 (2015).
24. Williams, J. C., Entcheva, E. Optogenetic versus Electrical Stimulation of Human Cardiomyocytes: Modeling Insights. Biophys J 108, 1934-1945 (2015).
25. Boyle, P. M., Williams, J. C., Ambrosi, C. M., Entcheva, E., Trayanova, N. A. A comprehensive multiscale framework for simulating optogenetics in the heart. Nat Commun 4, 2370 (2013).
26. Vassalli, G., Bueler, H., Dudler, J., Von Segesser, L. K., Kappenberger, L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 90, 229-238 (2003).
27. Bish, L. T. et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 19, 1359-1368 (2008).
28. Comtois, P., Nattel, S. Interactions between cardiac fibrosis spatial pattern and ionic remodeling on electrical wave propagation. Conf Proc IEEE Eng Med Biol Soc 2011, 4669-4672 (2011).
29. Moran, P. A. Notes on continuous stochastic phenomena. Biometrika 37, 17-23 (1950).
30. Kilgus, C. et al. Local gene targeting and cell positioning using magnetic nanoparticles and magnetic tips: comparison of mathematical simulations with experiments. Pharm Res 29, 1380-1391 (2012).
31. Lu, J. et al. Improving cardiac conduction with a skeletal muscle sodium channel by gene and cell therapy. J Cardiovasc Pharmacol 60, 88-99 (2012).
32. Qu, J. et al. Expression and function of a biological pacemaker in canine heart. Circulation 107, 1106-1109 (2003).
33. Nygren, J. M. et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10, 494-501 (2004).
34. Johnston, P. V. et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 120, 1075-1083 1077 p following 1083 (2009).
35. Shadrin, I. Y., Yoon, W., Li, L., Shepherd, N., Bursac, N. Rapid fusion between mesenchymal stem cells and cardiomyocytes yields electrically active, non-contractile hybrid cells. Sci Rep 5, 12043 (2015).
36. Zhang, F. et al. Multimodal fast optical interrogation of neural circuitry. Nature 446, 633-639 (2007).
37. Evans, J. D., Hearing, P. Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J Virol 77, 5295-5304 (2003).
38. Chartier, C. et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70, 4805-4810 (1996).
39. Zack, G. W., Rogers, W. E., Latt, S. A. Automatic measurement of sister chromatid exchange frequency. J Histochem Cytochem 25, 741-753 (1977).
40. Trayanova, N. A. Whole-heart modeling: applications to cardiac electrophysiology and electromechanics. Circ Res 108, 113-128 (2011).
41. Trayanova, N. A. Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and management. Circ Res 114, 1516-1531 (2014).
42. Luo, C. H., Rudy, Y. A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res 68, 1501-1526 (1991).
43. Korhonen, T., Hanninen, S. L., Tavi, P. Model of excitation-contraction coupling of rat neonatal ventricular myocytes. Biophys J 96, 1189-1209 (2009).
44. Zimmermann, D. et al. Biophysical characterisation of electrofused giant HEK293-cells as a novel electrophysiological expression system. Biochem Biophys Res Commun 348, 673-681 (2006).
45. Bishop, M. J., Plank, G. Representing cardiac bidomain bath-loading effects by an augmented monodomain approach: application to complex ventricular models. IEEE Trans Biomed Eng 58, 1066-1075 (2011).
46. Vigmond, E. J., Hughes, M., Plank, G., Leon, L. J. Computational tools for modeling electrical activity in cardiac tissue. J Electrocardiol 36 Suppl, 69-74 (2003).
47. Vigmond, E. J., Weber dos Santos, R., Prassl, A. J., Deo, M., Plank, G. Solvers for the cardiac bidomain equations. Prog Biophys Mol Biol 96, 3-18 (2008).
48. den Haan, A. D. et al. Organ explant culture of neonatal rat ventricles: a new model to study gene and cell therapy. PLoS One 8, e59290 (2013).
49. Costa, C. M. et al. An efficient finite element approach for modeling fibrotic clefts in the heart. IEEE Trans Biomed Eng 61, 900-910 (2014).
50. Shaw, R. M., Rudy, Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res 81, 727-741 (1997).